RxDoctor Payments DataLook up a doctor →

Marcy Abel, MD

Urogynecology and Reconstructive Pelvic Surgery · Nashville, TNNPI 1952388977

Payments from drug & device makers

$22,342in general payments, 2019–2025

Across 382 payments — averaging $58.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$15K
  • Axonics, Inc.$2K
  • Astellas Pharma US Inc$958
  • Sumitomo Pharma America, Inc.$776
  • Caldera Medical, Inc$631
  • AbbVie$568
  • plus $3K from 32 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$22,342 in reported general payments places this provider in the 75th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Tennessee.

See all urogynecology and reconstructive pelvic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$448,921
Medicare patients
653
Services billed
14,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urogynecology and reconstructive pelvic surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →